BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 7504442)

  • 1. In vivo imaging with fluorescent smart probes to assess treatment strategies for acute pancreatitis.
    Agarwal A; Boettcher A; Kneuer R; Sari-Sarraf F; Donovan A; Woelcke J; Simic O; Brandl T; Krucker T
    PLoS One; 2013; 8(2):e55959. PubMed ID: 23409095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trypsin Activity in Secretagogue-induced Murine Pancreatitis Is Solely Elicited by Cathepsin B and Does Not Mediate Key Pathologic Responses.
    Geisz A; Tran T; Orekhova A; Sahin-Tóth M
    Gastroenterology; 2023 Apr; 164(4):684-687.e4. PubMed ID: 36641042
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of ulinastatin in steroid-induced pancreatitis.
    Prithvi D; Kumar N; Kumar A; Kumar A
    BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38839406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulinastatin enhances the therapeutic effect of intraperitoneal lavage on severe acute pancreatitis in rats.
    Feng C; Su X; Chen LI; Zhou X; Li B; Wang LL; Lv FQ; Li TS
    Exp Ther Med; 2015 May; 9(5):1651-1655. PubMed ID: 26136873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of ulinastatin in patients with non-small cell lung cancer after radiation therapy: a randomized, placebo-controlled study.
    Bao P; Zhao W; Li Y; Liu Y; Zhou Y; Liu C
    Med Oncol; 2015 Jan; 32(1):405. PubMed ID: 25502081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of trypsin inhibitors derived from a spider venom peptide in L-arginine-induced severe acute pancreatitis in mice.
    Ning W; Wang Y; Zhang F; Wang H; Wang F; Wang X; Tang H; Liang S; Shi X; Liu Z
    PLoS One; 2013; 8(4):e61049. PubMed ID: 23613780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rational approach to the specific chemotherapy of pancreatitis.
    Hermon-Taylor J; Heywood GC
    Scand J Gastroenterol Suppl; 1985; 117():39-46. PubMed ID: 3912964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How and where does acute pancreatitis begin?
    Steer ML
    Arch Surg; 1992 Nov; 127(11):1350-3. PubMed ID: 1280081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human urinary trypsin inhibitor, urinastatin, prevents pancreatic injuries induced by pancreaticobiliary duct obstruction with cerulein stimulation and systemic hypotension in the rat.
    Hirano T; Manabe T
    Arch Surg; 1993 Dec; 128(12):1322-9; discussion 1329. PubMed ID: 7504442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats.
    Hirano T; Manabe T; Tobe T
    Dig Dis Sci; 1993 Apr; 38(4):660-4. PubMed ID: 7681748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible mechanism for gallstone pancreatitis: repeated short-term pancreaticobiliary duct obstruction with exocrine stimulation in rats.
    Hirano T; Manabe T
    Proc Soc Exp Biol Med; 1993 Feb; 202(2):246-52. PubMed ID: 7678705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
    Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
    Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new experimental model for gallstone pancreatitis: short-termed pancreatico-biliary duct obstruction and exocrine stimulation with systemic hypotension in rats.
    Hirano T; Manabe T
    Nihon Geka Hokan; 1993 Jan; 62(1):3-15. PubMed ID: 8352638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis.
    Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T
    Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.